CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue31,50113,368106,40728,658
Cost of Revenue89,13590,29664,39746,398
Gross Profit-57,634-76,92842,010-17,740
Operating Expenses
Research Development89,13589,13589,13589,135
Selling General and Administrative31,28236,46827,82319,667
Non Recurring----
Others----
Total Operating Expenses120,417126,76492,22066,065
Operating Income or Loss-88,916-113,39614,187-37,407
Income from Continuing Operations
Total Other Income/Expenses Net-13,182-14,3942,266-94
Earnings Before Interest and Taxes-88,916-113,39614,187-37,407
Interest Expense-21,564-16,996-2,698-268
Income Before Tax-106,289-127,79016,453-37,501
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-106,289-127,79016,453-37,501
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-106,289-127,79016,453-37,501
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-106,289-127,79016,453-37,501